With a robust background in the pharmaceutical industry spanning over 13 years, Mr. Irimescu brings a wealth of experience to his new role. He joined Roche in 2019 as the Director of Roche Diabetes Care Sub-Region Asia Frontier Markets, based in Singapore. Subsequently, he was appointed as the Head of Asia Emerging Markets Cluster at Roche Diabetes Care in January 2020, based in Thailand, from where he oversaw sustained growth and geographical expansion of our Diabetes Care business in fourteen markets. His appointment as the General Manager underscores his proven track record and leadership within the organization.
In his previous roles, Mr. Irimescu has demonstrated his expertise and professionalism in various capacities. Notably, he served as Vice President & General Manager of Thailand and Head of Strategic Pricing, Global Market Access at Novo Nordisk, based in Copenhagen, Denmark. His diverse background encompasses global, regional, and local market experience, making him well-equipped to drive Roche Diagnostics Thailand's sustainable success in the healthcare industry.
Reflecting on his new position, Mr. Irimescu expressed his commitment to positioning Roche Diagnostics (Thailand) as a trusted partner in the healthcare industry ecosystem. He emphasized the importance of improving access to diagnostic testing, therefore contributing to a sustainable healthcare system as well as to enhancing the quality of life of Thai people.
Mr. Irimescu holds a Master of Science in Management from BI Norwegian School of Management and has previously worked in the telecom and IT industries.
Source: World Digital PR